Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1998 May-Aug;71(3-4):311–323.

Diagnosis and treatment of ECL cell tumors.

G Cadiot 1, D Cattan 1, M Mignon 1
PMCID: PMC2578988  PMID: 10461362

Abstract

The diagnosis of ECL-omas is easy to perform. In patients with Zollinger-Ellison syndrome (ZES), ECL-omas are almost always observed in the setting of multiple endocrine neoplasia type I. In patients without ZES, the first step is to discard non-gastrin-related sporadic ECL-omas whose prognosis is poor. By contrast, prognosis of ECL-omas in patients with ZES or chronic atrophic gastritis is good. Metastases are rare, and tumor-related deaths are exceptional. In both conditions, ECL-omas measuring less than 1 cm should be treated by endoscopic polypectomy and survey. Treatment modalities (surgery, endoscopic polypectomy) for larger tumors are still discussed. The impact of endoscopic ultrasonography on the therapeutic decision has not yet been evaluated. Considering the good prognosis of these tumors, aggressive surgery could be limited to selected patients. Multicentric studies should be undertaken to determine the best treatment modalities.

Full text

PDF
311

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlman H., Kölby L., Lundell L., Olbe L., Wängberg B., Granérus G., Grimelius L., Nilsson O. Clinical management of gastric carcinoid tumors. Digestion. 1994;55 (Suppl 3):77–85. doi: 10.1159/000201206. [DOI] [PubMed] [Google Scholar]
  2. Armbrecht U., Stockbrügger R. W., Rode J., Menon G. G., Cotton P. B. Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. Gut. 1990 Oct;31(10):1105–1109. doi: 10.1136/gut.31.10.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bardram L., Agner T., Hagen C. Levels of alpha-subunits of gonadotropins can be increased in Zollinger-Ellison syndrome, both in patients with malignant tumours and with apparently benign disease. Acta Endocrinol (Copenh) 1988 May;118(1):135–141. doi: 10.1530/acta.0.1180135. [DOI] [PubMed] [Google Scholar]
  4. Borch K. Epidemiologic, clinicopathologic, and economic aspects of gastroscopic screening of patients with pernicious anemia. Scand J Gastroenterol. 1986 Jan;21(1):21–30. doi: 10.3109/00365528609034616. [DOI] [PubMed] [Google Scholar]
  5. Borch K., Renvall H., Liedberg G., Andersen B. N. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol. 1986 Apr;21(3):357–363. doi: 10.3109/00365528609003087. [DOI] [PubMed] [Google Scholar]
  6. Borch K., Renvall H., Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 1985 Mar;88(3):638–648. doi: 10.1016/0016-5085(85)90131-3. [DOI] [PubMed] [Google Scholar]
  7. Bordi C., Cocconi G., Togni R., Vezzadini P., Missale G. Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol. 1974 Oct;98(4):274–278. [PubMed] [Google Scholar]
  8. Bordi C., D'Adda T., Ceda G. P., Bertele A., Pilato F. P., Ceresini G., Baggi M. T., Missale G. Glycoprotein hormone alpha subunit in endocrine cells of human oxyntic mucosa. Studies on its relation to neuroendocrine tumors. Hepatogastroenterology. 1990 Feb;37(1):108–114. [PubMed] [Google Scholar]
  9. Bordi C., Yu J. Y., Baggi M. T., Davoli C., Pilato F. P., Baruzzi G., Gardini G., Zamboni G., Franzin G., Papotti M. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer. 1991 Feb 1;67(3):663–672. doi: 10.1002/1097-0142(19910201)67:3<663::aid-cncr2820670323>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  10. Cadiot G., Laurent-Puig P., Thuille B., Lehy T., Mignon M., Olschwang S. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology. 1993 Aug;105(2):579–582. doi: 10.1016/0016-5085(93)90736-v. [DOI] [PubMed] [Google Scholar]
  11. Cadiot G., Lehy T., Bonfils S. Action of somatostatin analogue (SMS 201-995) on the growth-promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour. Eur J Clin Invest. 1988 Aug;18(4):360–368. doi: 10.1111/j.1365-2362.1988.tb01024.x. [DOI] [PubMed] [Google Scholar]
  12. Cadiot G., Lehy T., Ruszniewski P., Bonfils S., Mignon M. Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci. 1993 Jul;38(7):1307–1317. doi: 10.1007/BF01296083. [DOI] [PubMed] [Google Scholar]
  13. Cadiot G., Vissuzaine C., Potet F., Mignon M. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig Dis Sci. 1995 Jun;40(6):1275–1278. doi: 10.1007/BF02065537. [DOI] [PubMed] [Google Scholar]
  14. Carney J. A., Go V. L., Fairbanks V. F., Moore S. B., Alport E. C., Nora F. E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med. 1983 Dec;99(6):761–766. doi: 10.7326/0003-4819-99-6-761. [DOI] [PubMed] [Google Scholar]
  15. Cattan D., Roucayrol A. M. Endocrinopathie fundique de la gastrite atrophique fundique avec achlorhydrie. II--Les tumeurs carcinoïdes. Gastroenterol Clin Biol. 1991;15(5 ):36C–40C. [PubMed] [Google Scholar]
  16. Cattan D., Roucayrol A. M., Launay J. M., Callebert J., Charasz N., Nurit Y., Belaiche J., Kalifat R. Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology. 1989 Sep;97(3):586–596. doi: 10.1016/0016-5085(89)90628-8. [DOI] [PubMed] [Google Scholar]
  17. D'Adda T., Annibale B., Delle Fave G., Bordi C. Oxyntic endocrine cells of hypergastrinaemic patients. Differential response to antrectomy or octreotide. Gut. 1996 May;38(5):668–674. doi: 10.1136/gut.38.5.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Eckhauser F. E., Lloyd R. V., Thompson N. W., Raper S. E., Vinik A. I. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report. Surgery. 1988 Dec;104(6):1046–1053. [PubMed] [Google Scholar]
  19. Ferraro G., Annibale B., Marignani M., Azzoni C., D'Adda T., D'Ambra G., Bordi C., delle Fave G. Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. J Clin Endocrinol Metab. 1996 Feb;81(2):677–683. doi: 10.1210/jcem.81.2.8636288. [DOI] [PubMed] [Google Scholar]
  20. Feurle G. E. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut. 1994 Feb;35(2):275–277. doi: 10.1136/gut.35.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gilligan C. J., Lawton G. P., Tang L. H., West A. B., Modlin I. M. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol. 1995 Mar;90(3):338–352. [PubMed] [Google Scholar]
  22. Gough D. B., Thompson G. B., Crotty T. B., Donohue J. H., Kvols L. K., Carney J. A., Grant C. S., Nagorney D. M. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg. 1994 Jul-Aug;18(4):473–480. doi: 10.1007/BF00353739. [DOI] [PubMed] [Google Scholar]
  23. Harvey R. F. Spontaneous resolution of multifocal gastric enterochromaffin-like cell carcinoid tumours. Lancet. 1988 Apr 9;1(8589):821–821. doi: 10.1016/s0140-6736(88)91677-7. [DOI] [PubMed] [Google Scholar]
  24. Hirschowitz B. I., Griffith J., Pellegrin D., Cummings O. W. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology. 1992 Apr;102(4 Pt 1):1409–1418. [PubMed] [Google Scholar]
  25. Lehy T., Cadiot G., Mignon M., Ruszniewski P., Bonfils S. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut. 1992 Sep;33(9):1275–1279. doi: 10.1136/gut.33.9.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lehy T., Mignon M., Cadiot G., Elouaer-Blanc L., Ruszniewski P., Lewin M. J., Bonfils S. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology. 1989 Apr;96(4):1029–1040. doi: 10.1016/0016-5085(89)91620-x. [DOI] [PubMed] [Google Scholar]
  27. Luts A., Uddman R., Absood A., Håkanson R., Sundler F. Chemical coding of endocrine cells of the airways: presence of helodermin-like peptides. Cell Tissue Res. 1991 Sep;265(3):425–433. doi: 10.1007/BF00340865. [DOI] [PubMed] [Google Scholar]
  28. MacFarlane M. P., Fraker D. L., Alexander H. R., Norton J. A., Lubensky I., Jensen R. T. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery. 1995 Dec;118(6):973–980. doi: 10.1016/s0039-6060(05)80102-3. [DOI] [PubMed] [Google Scholar]
  29. McCloy R. F., Arnold R., Bardhan K. D., Cattan D., Klinkenberg-Knol E., Maton P. N., Riddell R. H., Sipponen P., Walan A. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci. 1995 Feb;40(2 Suppl):96S–120S. doi: 10.1007/BF02214874. [DOI] [PubMed] [Google Scholar]
  30. Mignon M., Lehy T., Bonnefond A., Ruszniewski P., Labeille D., Bonfils S. Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer. 1987 Jun 1;59(11):1959–1962. doi: 10.1002/1097-0142(19870601)59:11<1959::aid-cncr2820591120>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  31. Modlin I. M., Gilligan C. J., Lawton G. P., Tang L. H., West A. B., Darr U. Gastric carcinoids. The Yale Experience. Arch Surg. 1995 Mar;130(3):250–256. doi: 10.1001/archsurg.1995.01430030020003. [DOI] [PubMed] [Google Scholar]
  32. Modlin I. M., Kumar R., Nangia A., Soroka C. J., Pasikhov D., Goldenring J. R. Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. Surgery. 1992 Dec;112(6):1048–1058. [PubMed] [Google Scholar]
  33. Modlin I. M., Tang L. H. The gastric enterochromaffin-like cell: an enigmatic cellular link. Gastroenterology. 1996 Sep;111(3):783–810. doi: 10.1053/gast.1996.v111.agast961110783. [DOI] [PubMed] [Google Scholar]
  34. Prinz C., Sachs G., Walsh J. H., Coy D. H., Wu S. V. The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology. 1994 Oct;107(4):1067–1074. doi: 10.1016/0016-5085(94)90231-3. [DOI] [PubMed] [Google Scholar]
  35. Rappel S., Altendorf-Hofmann A., Stolte M. Prognosis of gastric carcinoid tumours. Digestion. 1995;56(6):455–462. doi: 10.1159/000201276. [DOI] [PubMed] [Google Scholar]
  36. Reubi J. C., Waser B., Horisberger U., Halter F., Soroka C. J., Kumar R. R., Goldenring J. R., Modlin I. M. Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors. Endocrinology. 1992 Jul;131(1):166–172. doi: 10.1210/endo.131.1.1319317. [DOI] [PubMed] [Google Scholar]
  37. Rindi G., Bordi C., Rappel S., La Rosa S., Stolte M., Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996 Feb;20(2):168–172. doi: 10.1007/s002689900026. [DOI] [PubMed] [Google Scholar]
  38. Rindi G., Luinetti O., Cornaggia M., Capella C., Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993 Apr;104(4):994–1006. doi: 10.1016/0016-5085(93)90266-f. [DOI] [PubMed] [Google Scholar]
  39. Roucayrol A. M., Cattan D. Evolution of fundic argyrophil cell hyperplasia in nonantral atrophic gastritis. Gastroenterology. 1990 Nov;99(5):1307–1314. doi: 10.1016/0016-5085(90)91155-y. [DOI] [PubMed] [Google Scholar]
  40. Ruszniewski P., Podevin P., Cadiot G., Marmuse J. P., Mignon M., Vissuzaine C., Bonfils S., Lehy T. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas. 1993 May;8(3):295–304. doi: 10.1097/00006676-199305000-00003. [DOI] [PubMed] [Google Scholar]
  41. Ruszniewski P., Ramdani A., Cadiot G., Lehy T., Mignon M., Bonfils S. Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest. 1993 May;23(5):296–301. doi: 10.1111/j.1365-2362.1993.tb00777.x. [DOI] [PubMed] [Google Scholar]
  42. Sjöblom S. M., Sipponen P., Järvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut. 1993 Jan;34(1):28–32. doi: 10.1136/gut.34.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sjöblom S. M., Sipponen P., Karonen S. L., Järvinen H. J. Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours. J Clin Pathol. 1989 Apr;42(4):371–377. doi: 10.1136/jcp.42.4.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sjöblom S. M., Sipponen P., Miettinen M., Karonen S. L., Jrvinen H. J. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy. 1988 Mar;20(2):52–56. doi: 10.1055/s-2007-1018130. [DOI] [PubMed] [Google Scholar]
  45. Solcia E., Bordi C., Creutzfeldt W., Dayal Y., Dayan A. D., Falkmer S., Grimelius L., Havu N. Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1988;41(4):185–200. doi: 10.1159/000199786. [DOI] [PubMed] [Google Scholar]
  46. Solcia E., Capella C., Fiocca R., Rindi G., Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol. 1990 Jun;14(6):503–513. doi: 10.1097/00000478-199006000-00001. [DOI] [PubMed] [Google Scholar]
  47. Stockbrügger R. W., Menon G. G., Beilby J. O., Mason R. R., Cotton P. B. Gastroscopic screening in 80 patients with pernicious anaemia. Gut. 1983 Dec;24(12):1141–1147. doi: 10.1136/gut.24.12.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Syversen U., Mignon M., Bonfils S., Kristensen A., Waldum H. L. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol. 1993;32(2):161–165. doi: 10.3109/02841869309083906. [DOI] [PubMed] [Google Scholar]
  49. Thomas R. M., Baybick J. H., Elsayed A. M., Sobin L. H. Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer. 1994 Apr 15;73(8):2053–2058. doi: 10.1002/1097-0142(19940415)73:8<2053::aid-cncr2820730807>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  50. Tsutsui S., Shinomura Y., Kanayama S., Yabu M., Miyazaki Y., Kawabata S., Kondo S., Murayama Y., Imamura I., Matsuzawa Y. Inhibition of gastrin-stimulated enterochromaffin-like cell proliferation and mucosal histamine production in the rat stomach by the somatostatin analogue octreotide. Regul Pept. 1995 May 30;57(2):175–182. doi: 10.1016/0167-0115(95)00029-b. [DOI] [PubMed] [Google Scholar]
  51. Walker F. M., Lehy T., Bernuau D. G., Sobhani I., Bayle D., Feldmann G., Lewin M. J. Detection of gastrin mRNA in human antral mucosa and digestive endocrine tumors by in situ hybridization: a correlative study with immunocytochemistry and electron microscopy. J Histochem Cytochem. 1992 Sep;40(9):1363–1372. doi: 10.1177/40.9.1506673. [DOI] [PubMed] [Google Scholar]
  52. Weber H. C., Venzon D. J., Lin J. T., Fishbein V. A., Orbuch M., Strader D. B., Gibril F., Metz D. C., Fraker D. L., Norton J. A. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology. 1995 Jun;108(6):1637–1649. doi: 10.1016/0016-5085(95)90124-8. [DOI] [PubMed] [Google Scholar]
  53. Wilander E., El-Salhy M., Pitkänen P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology. 1984 Mar;8(2):183–193. doi: 10.1111/j.1365-2559.1984.tb02335.x. [DOI] [PubMed] [Google Scholar]
  54. Yoshikane H., Tsukamoto Y., Niwa Y., Goto H., Hase S., Mizutani K., Nakamura T. Carcinoid tumors of the gastrointestinal tract: evaluation with endoscopic ultrasonography. Gastrointest Endosc. 1993 May-Jun;39(3):375–383. doi: 10.1016/s0016-5107(93)70109-1. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES